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Background: Individuals with typical circadian rhythm sleep-wake disorders (CRSWDs) have a habitual sleep
timing that is desynchronized from social time schedules. However, it is possible to willfully force synchroni-
sation against circadian-driven sleepiness, which causes other sleep problems. This pathology is distinguish-
able from typical CRSWDs and is referred to here as latent CRSWD (LCRSWD). Conventional diagnostic
methods for typical CRSWDs are insufficient for detecting LCRSWD because sufferers have an apparently nor-
mal habitual sleep timing.
Methods: We first evaluated the reliability of circadian phase estimation based on clock gene expression
using hair follicles collected at three time points without sleep interruption. Next, to identify detection crite-
ria for LCRSWD, we compared circadian and sleep parameters according to estimated circadian phases, at the
group and individual level, between subjects with low and high Pittsburgh Sleep Quality Index (PSQI) scores.
To validate the reliability of identified detection criteria, we investigated whether the same subjects could be
reproducibly identified at a later date and whether circadian amelioration resulted in sleep improvement.
Findings:We successfully validated the reliability of circadian phase estimation at three time points and iden-
tified potential detection criteria for individuals with LCRSWD attributed to delayed circadian-driven sleepi-
ness. In particular, a criterion based on the interval between the times of the estimated circadian phase of
clock gene expression and getting out of bed on work or school days was promising. We also successfully
confirmed the reproducibility of candidate screening and sleep improvement by circadian amelioration, sup-
porting the reliability of the detection criteria.
Interpretation: Although several limitations remain, our present study demonstrates a promising prototype of
a detection method for LCRSWD attributed to delayed circadian-driven sleepiness. More extensive trials are
needed to further validate this method.
Funding: This study was supported mainly by JSPS, Japan.
© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/)Keywords:
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Sleep disorders are caused by a wide range of internal and exter-
nal factors [15], indicating the need for reliable identification of
specific causes in a personalized manner for proper medical treat-
ment. Sleep disorders attributed to circadian dysfunction are called
circadian rhythm sleep-wake disorders (CRSWDs), which are subdi-
vided into several disorders: advanced sleep-wake phase disorder,
delayed sleep-wake phase disorder, non-24 h sleep-wake rhythm
disorder and irregular sleep-wake rhythm disorder [610]. Thesetypical CRSWDs have been reported to affect approximately 1% to 3%
of the population [1114]. Patients suffering from CRSWDs are char-
acterized by the desynchrony in their habitual sleep timing from
social time schedules. Diagnosis of CRSWDs is therefore relatively
easy because the desynchrony from social time schedules is simply
and clearly detectable using sleep diaries and actograms [1517]. In
the clinical treatment of patients diagnosed with CRSWDs, g-amino-
butyric acid (GABA) receptor agonists and orexin receptor antago-
nists may be counterproductive. Instead, the circadian clock should
be adjusted using bright light and/or melatonin receptor agonists to
help synchronize the patient’s circadian-driven sleepiness with social
time schedules [8,18,19].
Patients suffering from typical CRSWDs, as described above, have
a habitual sleep timing that is desynchronized from social time
Research in Context
Evidence before this study
Sleep disorders attributed to circadian dysfunction are called
circadian rhythm sleep-wake disorders (CRSWDs). Individuals
with typical CRSWDs have a habitual sleep timing that is
desynchronized from social time schedules. However, it is pos-
sible to willfully force synchronisation against circadian-driven
sleepiness, which causes other sleep problems. This type of
CRSWD is referred to here as latent CRSWD (LCRSWD). Given
that one-third of the European population suffers from 2 h or
more of social jetlag, the number of people suffering from
LCRSWD could be substantial. Nevertheless, conventional diag-
nostic methods for typical CRSWDs are insufficient for detect-
ing LCRSWD because sufferers have an apparently normal
habitual sleep timing.
Added value of this study
In this study, we compared circadian and sleep parameters
according to estimated circadian phases between subjects with
and without sleep difficulties and identified potential detection
criteria for LCRSWD. Furthermore, we evaluated the reliability
of these detection criteria through follow-up investigations and
successfully confirmed the reproducibility of candidate screen-
ing and sleep improvement by circadian amelioration. Our
present study therefore demonstrates a promising prototype of
a detection method for LCRSWD.
Implications of all the available evidence
The number of people potentially suffering from LCRSWD is
likely considerable, particularly among younger generations.
Although circadian amelioration is a causal treatment for
patients with LCRSWD, these patients might be prescribed gen-
eral symptomatic treatments for sleep problems due to the lack
of a well-established diagnostic method for LCRSWD. Our
detection method will contribute to realizing more reliable
diagnosis of LCRSWD for proper medical treatment.
2 M. Akashi et al. / EBioMedicine 62 (2020) 103080schedules due to abnormal circadian-driven sleepiness. However, it is
possible for people to force their own habitual sleep timing to syn-
chronize with social time schedules against circadian-driven sleepi-
ness. In this case, the misalignment between circadian-driven
sleepiness and habitual sleep timing that is synchronized with social
time schedules causes other sleep problems. Given that the patient’s
apparent habitual sleep timing is normal, this type of CRSWD is dis-
tinguishable from typical CRSWDs. Although the third edition of the
International Classification of Sleep Disorders describes this disease
state as one of the pathologies of CRSWDs [10], there remains no spe-
cific definition or terminology. In the present study, we describe this
type of CRSWD as latent CRSWD (LCRSWD) (Fig. 1). While patients
with typical CRSWDs have a habitual sleep timing that is synchro-
nized with circadian-driven sleepiness but not with social time
schedules, patients with LCRSWD have a habitual sleep timing that is
synchronized with social time schedules but not with circadian-
driven sleepiness. Given modern environments and lifestyle habits,
the number of people potentially suffering from LCRSWD may be
substantial, particularly among younger generations. Social jetlag,
which is calculated based on the difference between the midpoints of
sleep on work days and days off (without alarm clocks), is an often-
used index to quantify the discrepancy between circadian and social
clocks. A large-scale survey of European participants revealed that
one-third of the population suffers from 2 h or more of social jetlag[20]. Because social jetlag does not necessarily but can potentially
cause circadian-related sleep problems, this epidemiological study
on social jetlag strongly indicates that the number of people suffering
from LCRSWD is considerable, particularly among younger genera-
tions. In the treatment of patients with LCRSWD, as for typical
CRSWDs, bright light exposure and/or administration of melatonin
receptor agonists help synchronize circadian-driven sleepiness with
habitual sleep timing and social time schedules.
Administration of proper medical treatment to patients with
LCRSWD requires the establishment of a reliable diagnostic method for
LCRSWD. While sleep parameters such as awakening and bedtime
hours obtained using sleep diaries and actograms are powerful for
diagnosing typical CRSWDs, they are insufficient for detecting LCRSWD
because the habitual sleep timing of patients is synchronized with
social time schedules. However, the habitual sleep timing on days off
independent of social time schedules likely reflects the phase of circa-
dian-driven sleepiness [20]. Therefore, a larger difference in the habit-
ual sleep timing between work days and days off is more likely to
indicate LCRSWD. On this basis, comparison of awakening and bedtime
hours between work days and days off is a helpful initial evaluation of
an individual’s potential risk of LCRSWD. However, it remains unclear
which parameters related to habitual sleep timing are more direct indi-
cators of LCRSWD.
Reliable diagnosis of LCRSWD requires biological markers because
while the habitual sleep timing on days off reflects the phase of circa-
dian-driven sleepiness, it can be affected by various non-circadian fac-
tors, particularly sleep debt. The circadian clock defines the phase of
circadian-driven sleepiness [21,22]. Comparison of the circadian clock
phase estimated using biological markers with the habitual sleep tim-
ing may therefore enable evaluation of the potential risk of LCRSWD,
with abnormal intervals between these phases indicating misalign-
ment between circadian-driven sleepiness and the habitual sleep tim-
ing. Although melatonin is thought to be a reliable biological marker
for the circadian clock phase in a research setting [6,7,23], it is associ-
ated with several limitations: the functional role of endogenous mela-
tonin in the circadian oscillator is unclear [24,25], and subjects must
remain under dim light conditions during sample collection because
melatonin levels are decreased in response to light input [26].
Although a reported method using metabolites is powerful for circa-
dian phase estimation and can overcome limitations inmelatoninmea-
surement [27], application of this method in clinical settings requires
overcoming the cost barrier. Circadian clock phase estimation based on
peripheral clock gene expression may therefore be an alternative
option for experimental evaluation of the potential risk of LCRSWD.
In the present study, we first evaluated the reliability of circadian
phase estimation based on clock gene expression using hair follicles
collected at three time points. Next, we aimed to identify potential
detection criteria for individuals with LCRSWD by examining circa-
dian and sleep parameters based on the estimated circadian phases.
To validate the identified detection criteria, we investigated the




This study was conducted in accordance with the Declaration of
Helsinki and all procedures were approved by the institutional
review boards of Yamaguchi University and Saga University, with all
subjects providing written informed consent.
2.2. Subjects
A total of 24 subjects (9 males and 15 females) with a Pittsburgh
Sleep Quality Index (PSQI) score  5 were defined as the control
Fig. 1. Typical circadian rhythm sleep-wake disorders (CRSWDs) and latent CRSWD (LCRSWD).
In individuals with normal sleep, the habitual sleep timing is synchronized with social time schedules and circadian-driven sleepiness (i.e., sleepiness independent of homeo-
static sleep pressure but under the control of the circadian clock). While patients with typical CRSWDs have a habitual sleep timing that is synchronized with circadian-driven sleep-
iness but not with social time schedules, patients with LCRSWD have a habitual sleep timing that is synchronized with social time schedules but not with circadian-driven
sleepiness.
M. Akashi et al. / EBioMedicine 62 (2020) 103080 3group, and 23 subjects (8 males and 15 females) with a PSQI score> 5
were assigned to the H-PSQI group. Because all subjects were able to
adapt themselves to social time schedules during all experimental
periods, none of them had typical CRSWD. The subjects in the two
groups had comparable age, body mass index (BMI) and smoking sta-
tus, as shown in Table 1. No subjects in either group took sleep medi-
cation. The Japanese version of the Morningness-Eveningness
Questionnaire (MEQ) was used to assess the chronotype of all sub-
jects [28]. In addition, all subjects completed the Japanese version of
the Munich Chronotype Questionnaire (MCTQ), which is a powerful
tool for obtaining well-defined sleep parameters such as GUw, local
time of getting out of bed on work or school days; SOw, sleep onset
on work or school days; GUf, local time of getting out of bed on free
days; and SOf, sleep onset on free days [29].
2.3. Experimental design
In contrast to typical CRSWDs, subjects with LCRSWD should be
classified under the H-PSQI group because the misalignment between
circadian-driven sleepiness and habitual sleep timing on work daysTable 1
Demographic, sleep and circadian characteristics of groups with low a
Characteristic Control Group (PSQI  5) n = 2
Sex, male/female 9/15
Age, y (SD) 23.17 (5.86)
BMI (SD) 20.19 (2.19)
Overweight (BMI: 25.029.9), No. 1
Sleep medication, yes/no 0/24
Smoking status, yes/no 2/22
PSQI score (SD) 2.71 (1.55)
MEQ score (SD) 54.25 (8.26)
Morning type, No. 8
Neither type, No. 14
Evening type, No. 2
Abbreviations: BMI, Body Mass Index; PSQI, Pittsburgh Sleep Quality I
a Statistical comparisons of groups with low and high PSQI scores w
Fisher's exact test.
b The method of Benjamini-Hochberg was used to calculate adjustecauses quantitative and qualitative sleep problems. Based on an epi-
demiological study on social jetlag [20], we hypothesized that
LCRSWD is one of the major contributors to sleep problems, particu-
larly among younger generations. Therefore, we first compared circa-
dian and sleep parameters between the control and H-PSQI groups to
identify detection criteria for LCRSWD. Although sleep problems
are caused by a wide range of internal and external factors in a com-
binatory manner, the population-level contribution of circadian dys-
function to sleep problems can be evaluated through statistical
comparison of these parameters between the control and H-PSQI
groups. Circadian-related parameters showing a major difference
between the groups are expected to be promising candidate detec-
tion criteria for LCRSWD. Following these statistical intergroup com-
parisons, we next conducted interindividual comparisons of these
parameters. Subjects completed the PSQI, MEQ and MCTQ, and had
scalp hair follicles collected at three time points (right after awaken-
ing, in the afternoon and right before bedtime) at approximately
8hr intervals around the clock without sleep interruption.
Based on details of informed consent, all subjects were provided a
brief summary of the experimental results. In response to thisnd high PSQI scores.
4 High PSQI Group (PSQI > 5) n = 23 P Valuea, b
8/15 0.23 (0.37)
21.13 (1.25) 0.11 (0.29)




11.26 (3.25) < 0.001 (< 0.001)




ndex; MEQ, Morningness-Eveningness Questionnaire.
ere performed using the unpaired two-tailed Student's t-test or
d P values (in parentheses).
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decided themselves to try a well-known general method for circadian
amelioration. Subjects with LCRSWD should show improved sleep
following circadian amelioration because their sleep problems are
largely attributed to circadian dysfunction. We therefore continued
observational experiments to evaluate whether we could detect
LCRSWD based on our criteria. Based on our expert advice, the sub-
jects followed the three rules described below for as many days as
possible to ameliorate their delayed circadian-driven sleepiness. First,
subjects exposed themselves to sunlight for more than 30 min in the
morning. They were informed that this sunlight exposure should be
done within 2 h of awakening. Second, subjects refrained from using
light-emitting devices such as smartphones and computers two
hours before bedtime. Third, subjects reduced the time-lag of morn-
ing awakening between work/school and free days. To avoid inducing
excessive mental and physical stress, we recommended that subjects
reduce their sleep debt by having an earlier bedtime on free days.
These three rules for circadian amelioration were performed for a
period of more than three weeks and continued for as long as possi-
ble based on the subject’s decision according to their mental and
physical conditions.
2.4. Peripheral clock gene expression
To identify the optimal time interval for sample collection at three
time points, we performed circadian phase estimation with various
time intervals using a cosine curve fitted to actual measurements
obtained for healthy volunteers. We found that the accuracy of circa-
dian phase estimation was highest at a time interval of about 8 h.
Scalp hair follicles were collected by gripping and tugging the hair
shaft with a pair of tweezers. The hair shafts, which were at least par-
tially covered with hair follicle cells, were quickly soaked in cell lysis
buffer (RNAqueous-Micro Kit; Thermo Fisher Scientific, U.S.A.). Hair
follicle cells attached to the hair shafts were stored at below 20 °C
until total RNA purification. Approximately 210 scalp hair follicles
were required at each time point to stably and reproducibly detect
clock gene expression. To minimize skin damage, hair follicles were
collected from different regions of the scalp. After mild homogenisa-
tion by hand and removal of the hair shaft, the RNAqueous-Micro Kit
was used to purify total RNA. After checking the quality and concen-
tration using a NanoDrop (LMS, Japan), total RNA was reverse-tran-
scribed using a SuperScript VILO cDNA Synthesis Kit (Life
Technologies, U.S.A.), and real-time PCR was performed using a Taq-
Man MGB probe (Applied Biosystems, U.S.A.) and a 1/20-volume of
the reverse transcription product. Data were obtained using
PRISM7300 (Applied Biosystems, U.S.A.) and normalised against 18S
ribosomal RNA (18S-rRNA), the expression of which is constant
regardless of cell type and sampling time [30]. Primer and probe
sequences of the Period 3 (Per3), Nr1d1 (nuclear receptor subfamily 1
group D member 1, also known as Rev-erba), Nr1d2 (nuclear receptor
subfamily 1 group D member 2, also known as Rev-erbb) and 18S-rRNA
transcripts are listed in our previous report [31].
2.5. Circadian phase estimation based on expression data from two
clock genes at three time points
The circadian clock, which is driven by autonomous transcriptional
oscillation of clock genes, defines the phase of circadian-driven sleepi-
ness. Because the phase intervals among clock gene transcripts are sim-
ilar regardless of cell type [30], any clock gene transcript can be used as
a phase marker for circadian-driven sleepiness. The peak time of Per3
transcripts (Per3 peak time, P3PT) was used as the phase marker in the
present study. Themethod used to estimate P3PT is described below.
First, the time-course of gene expression was normalized to fit to
24-h-period cosine curves with unity amplitude. The normalized
gene expression at time t was denoted x(t) and y(t) for Per3 andNr1d2, respectively. Second, gene expression data from the two genes
were fitted to the following 24-h-period cosine curves under the con-
straint that Per3 and Nr1d2 had a phase difference of Du:
x tð Þ ¼ Ax cosðvt þ uÞ þ Cx
y tð Þ ¼ Ay cosðvt þ qþDqÞ þ Cy
For measurements conducted at three time points, the cost func-
tion was defined as
Eðu;A;CÞ ¼
X3
i¼1½fx tið ÞAx cosðvti þ uÞCxg
2
þ fy tið ÞAy cosðvti þ u þDuÞCyg2;
where v ¼ 2p=24. The model parameters, fu;Ax;Ay;Cx;Cyg, were
determined so as to minimize the cost function using the conjugate
gradient method. Empirically, the difference in peak expression time
between the two clock genes is known to be around Dt ¼ 2 h, which
is translated to the phase difference of Du ¼ 2pDt=24. The optimal
phase difference, which gives the minimum cost function, was
selected by varying the phase difference in the range Dt [1.5 h,
2.5 h]. Finally, the peak expression time of Per3 was estimated to be
CTPer3 = 24(0.5pu)/(2p). To evaluate goodness of fit, the coefficient
of determination was also calculated from the three-point data.
2.6. Statistical analysis
No statistical methods were used to predetermine the sample size
due to the lack of available prevalence estimation for LCRSWD. Statisti-
cal comparisons of groups with low and high PSQI scores were per-
formed using the unpaired two-tailed Student's t-test or Fisher's exact
test. The Benjamini-Hochberg method was used to calculate adjusted P
values. Linear correlation between estimated circadian phases and
sleep parameters was evaluated using Pearson correlation. P < 0.05
indicated statistical significance. Receiver Operating Characteristic
(ROC) analysis was performed using MATLAB (R2020a, MathWorks).
2.7. Role of funding source
The funders had no role in the study design, data collection, data
analysis, data interpretation, writing of the report or the decision to
publish.
3. Results
3.1. Validation of circadian phase estimation based on expression of two
clock genes at three time points
We validated the reliability of circadian phase estimation based
on expression data from two clock genes (Per3 and Nr1d2) at three
time points using sample data sets obtained from healthy subjects
(Fig. 2a). Scalp hair follicle cells were collected from four subjects at
three time points at approximately eight-hour intervals without
sleep interruption. Four independent samples were collected at each
time point to perform accuracy validation of circadian phase estima-
tion. Because the phase interval between Per3 and Nr1d2 circadian
expression is mostly constant among individuals [31], cosine fitting
was conducted under the condition that the Per3 and Nr1d2 phase
interval was within a range of 2 § 0.5 h. Circadian phase (i.e. P3PT)
was estimated in 64 combinations because we had four independent
samples for each time point, and we defined the mean of all 64 esti-
mated circadian phases as the real phase. The estimation error and
coefficient of determination (CD) were obtained from the 64 estima-
tions for each subject (Fig. 2b). Investigation of the relationship
between the estimation error and CD revealed that the mean error
was about one hour when CD was greater than 95%.
Fig. 2. Validation of circadian phase estimation based on expression of two clock genes at three time points.
Scalp hair follicles were collected from four subjects at three time points at approximately 8h intervals without sleep interruption. Four independent samples were collected at
each time point to perform accuracy validation of circadian phase estimation. Total RNA was subjected to realtime PCR for quantification of the expression levels of Per3 and Nr1d2.
Expression levels were normalized based on the expression level of 18S ribosomal RNA.
(a) For four subjects (I, II, II and IV), 64 combinations of data from three time points were constructed from differently but simultaneously sampled data. Cosine curve fitting was
performed for each combination of Per3 and Nr1d2 expression data, and the 64 fitted curves were then overlaid. Variability in the fitted curves represents the estimation error. The
mean of 64 estimated circadian phases was defined as the real phase. The real phase § standard deviation is shown for each subject.
(b) Dependence of the estimation error (i.e., deviation of the estimated phase from the mean phase) on the coefficient of determination of cosine fitting.
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comparison of groups with low and high PSQI scores
To identify variables specific to LCRSWD, sleep and circadian
parameters were statistically compared between groups with low
(PSQI  5, control group) and high PSQI scores (PSQI > 5, H-PSQI
group) (Tables 1 and 2). The H-PSQI group had a significantly lower
MEQ score than the control group (Table 1). SOw, GUf and SOf were
significantly delayed by an average of about one hour in the H-PSQI
group (Table 2). SOw  P3PT was significantly larger in the H-PSQI
group. Although we validated the estimation of P3PT using expres-
sion data from two genes (2 G, Per3 and Nr1d2) at three time points
in Fig. 2, for further confirmation, we reproduced all estimates using
expression data from three genes (3 G, Per3, Nr1d1 and Nr1d2). These
results provided no potential detection criteria for LCRSWD.
Linear correlation analysis was performed between estimated cir-
cadian phases and sleep parameters (Supplementary Figure 1).
According to two-dimensional scatter plots (P3PT versus MEQ, GUw,
SOw, GUf or SOf), while there was a moderate positive correlation (r
> 0.3) between P3PT and GUw in the control group, there was no
such correlation in the H-PSQI group. A moderate positive correlation
was observed between P3PT and SOw in both groups. Despite SOw
being significantly delayed in the H-PSQI group (Table 2), the level of
correlation between P3PT and SOw was similar to that in the control
group. These results suggest that the relationship between GUw and
P3PT may define the detection criteria for LCRSWD. However, due to
the large confidence intervals (CIs), the present sample size was
insufficient to make any robust interpretations.3.3. Identification of detection criteria for LCRSWD through
interindividual comparison between groups with low and high PSQI
scores
Circadian and sleep parameters were compared at the individual
level between groups with low and high PSQI scores (Fig. 3). In both
groups, many subjects showed larger GUf  GUw than SOf  SOw.Although there was no significant difference in GUf  GUw between
the groups (Table 2), two subjects in the control group had a
GUf  GUw of more than two hours compared to eight subjects in the
H-PSQI group. In particular, Subjects C and L showed a GUf  GUw of
four hours. To facilitate visual identification of potential abnormalities,
the 1 SD range of values from the control group is shown on every dot
plot in Fig. 3 (top line, mean + SD; bottom line, mean  SD). Although
the distribution of P3PT in the H-PSQI group was similar to that in the
control group, the GUw  P3PT value showed larger individual differ-
ences in the H-PSQI group. Subjects C and L had a GUw  P3PT value
less than the mean SD of the control group. Nearly half of the H-PSQI
subjects had a SOw  P3PT greater than the mean + SD of the control
group. According to these results, two criteria were set for LCRSWD
due to delayed circadian-driven sleepiness: a GUf  GUw of about
three hours or more and a GUw P3PT less than the mean SD of the
control group. Subjects C, K and L met both criteria.3.4. Reproducibility of candidate screening
After about two months, a second screen was conducted for H-
PSQI subjects with a GUf  GUw of more than two hours or
GUw  P3PT less than the mean  SD of the control group in the first
assessment. Seven H-PSQI subjects agreed to this second assessment.
Subjects M and P, who had met neither of the criteria in the first
assessment, were recruited as negative control subjects. All nine sub-
jects again showed a high PSQI score (> 5). Compared to the first
assessment, GUf  GUw decreased in Subject K, remained at about
four hours in Subjects C and L and increased to more than four hours
in Subject I (Fig. 4a, left). While GUw  P3PT improved in Subjects B,
F, H and K in the second assessment, the value was reproducibly and
newly less than the mean  SD of the control group in Subjects L and
I, respectively (Fig. 4a, right). Subject C had severe circadian dysfunc-
tion because clock gene expression showed no circadian rhythms.
Thus, Subjects C, I, and L were suspected of having LCRSWD.
To evaluate the accuracy of prediction of LCRSWD based on only a
single criterion (GUw  P3PT or GUf  GUw), area under the curve
Table 2
Statistical comparison of sleep and circadian parameters between groups with low and high PSQI scores.
Characteristic Control Group (PSQI  5) n = 24 High PSQI Group (PSQI > 5) n = 23 P Valuea
Mean SD Mean SD
Working or school day
GUw (local time) 7.99 0.81 8.45 1.14 0.111
SOw (local time) 24.52 0.79 25.78 1.01 0.000*
Free day
GUf (local time) 9.16 1.22 10.07 1.55 0.031*
SOf (local time) 25.05 1.07 26.03 1.21 0.005*
Time lag
GUf  GUw (h) 1.17 0.89 1.61 1.29 0.178
SOf  SOw (h) 0.52 0.75 0.25 0.92 0.277
Per3 peak time (P3PT)
2 G (local time) 6.40 1.14 6.57 0.82 0.564
3 G (local time) 6.45 1.32 6.68 0.93 0.497
Time interval (2 G)
GUw  P3PT (h) 1.59 1.16 1.89 1.48 0.445
SOw  P3PT (h) 18.12 1.16 19.21 0.99 0.001*
GUf  P3PT (h) 2.76 1.56 3.50 1.78 0.138
SOf  P3PT (h) 18.65 1.50 19.47 1.42 0.061
Time interval (3 G)
GUw  P3PT (h) 1.54 1.28 1.77 1.52 0.564
SOw  P3PT (h) 18.07 1.26 19.10 0.94 0.003*
GUf  P3PT (h) 2.71 1.58 3.39 1.84 0.182
SOf  P3PT (h) 18.60 1.56 19.35 1.45 0.092
Abbreviations: GUw, local time of getting out of bed on working or school days; SOw, sleep onset on working or school
days; GUf, local time of getting out of bed on free days; SOf, sleep onset on free days; 2 G, local time of Per3 peak time esti-
mated using three-point expression data of two genes, Per3 and Nr1d2; 3 G, local time of Per3 peak time estimated using
three-point expression data of three genes, Per3, Nr1d1 and Nr1d2.
a Statistical comparisons of groups with low and high PSQI scores were performed using the unpaired two-tailed Stu-
dent's t-test.
6 M. Akashi et al. / EBioMedicine 62 (2020) 103080(AUC) was calculated from ROC curves (Supplementary Figure 2a). The
value of AUC was more than 0.9 for each criterion, indicating that the
prediction of LCRSWD is highly reliable. The optimal cut-off value for
single-criterion prediction was 0.15 for GUw  P3PT (2 G), 0.16 for
GUw P3PT (3 G) and 3 for GUf GUw (Supplementary Figure 2b).
3.5. Effect of circadian amelioration on sleep
Based on our experimental results, in addition to Subjects C and L,
Subject I, who showed obvious abnormalities in both criteria in the
second assessment, underwent circadian amelioration by following
the three rules detailed in the Methods section. We assessed their cir-
cadian and sleep parameters to validate our detection criteria. Three
or four weeks later, these subjects completed the PSQI, MCTQ and
MEQ and their hair follicles were collected at about eight hour inter-
vals without sleep interruption. After these assessments, they contin-
ued to follow the rules for circadian amelioration for as long as
possible. Compared to the first and second assessments, Subjects I
and L had a shorter GUf  GUw value, a GUw  P3PT value within
the 1 SD range of the control group and a lower PSQI score (Fig. 4b).
While P3PT steadily advanced in Subject I, in Subject L, it had
advanced four weeks after the start of circadian amelioration but sub-
sequently reversed back to the original value (Fig. 4c and 4d). In Sub-
ject C, although transcriptional oscillation was restored, no
improvement was observed in the PSQI score (Fig. 4b, 4c and 4d).
4. Discussion
4.1. Circadian phase estimation at three time points
Patients with typical CRSWDs have a habitual sleep timing that is
synchronized with circadian-driven sleepiness but not with social
time schedules. In contrast, patients with LCRSWD have a habitual
sleep timing that is synchronized with social time schedules but not
with circadian-driven sleepiness. Although both CRSWDs and
LCRSWD are attributed to circadian dysfunction, differences in theirpathological mechanism remain unclear. Our long-term goal is to
establish a detection method for LCRSWD for use in clinical settings.
In the present study, we aimed to create a prototype of this method.
To minimize burden on patients and medical workers, low sample
collection frequency and a simple measurement procedure are
required for circadian phase estimation using biological markers. Our
previous reports demonstrated that scalp and facial hair follicle cells
are useful for circadian phase estimation [31] and indicated that reli-
able circadian phase estimation was possible based on expression
data from three clock genes (Per3, Nr1d1 and Nr1d2) at four time
points per day [32]. To realize sample collection without sleep inter-
ruption and further improve practicality, we validated the reliability
of circadian phase estimation based on expression data from two
clock genes at three time points (at approximately eight-hour inter-
vals). The real phase (the mean of 64 estimated circadian phases) and
standard deviation (SD) calculated for each subject suggested that
circadian phase estimation based on the expression of two clock
genes at three time points was practicable.
The mean error was about one hour when CD was greater than
95%. In subsequent experiments, about 5% of the data had a CD less
than 95%. The value of CD is therefore a useful reliability indicator for
circadian phase estimation. Lower CD values indicate lower reliability
of estimated circadian phases, suggesting the existence of either
technical issues related to the experimental procedure or a pathologi-
cal sign due to circadian dysfunction.
4.2. Statistical search for detection criteria for LCRSWD
Consistent with MEQ scores, SOw, GUf and SOf were significantly
delayed by an average of about one hour in the H-PSQI group. How-
ever, because a delayed sleep phase is not only caused by circadian
dysfunction but also often results from a delayed habitual bedtime or
difficulties with sleep onset, these parameters are not highly specific
to LCRSWD. Although the H-PSQI group showed delayed GUw by an
average of about 30 min, there was no statistically significant differ-
ence between groups. This is because GUw is strongly affected by
Fig. 3. Interindividual comparison of sleep and circadian parameters between groups with low and high PSQI scores.
The first and second panels from the top show GUf  GUw (yellow bars) and SOf  SOw (gray bars) for each subject, respectively. The dot plots show the value of P3PT,
GUw  P3PT and SOw  P3PT with 95% CI for each subject (red dots, P3PT estimated from 2 genes; blue dots, P3PT estimated from 3 genes). To facilitate visual identification of
potential abnormalities, the 1 SD range of values from the control group was indicated on every dot plot for both the control and H-PQSI groups (top line, mean + SD; bottom line,
mean  SD). For example, the top and bottom lines shown in the P3PT plot for the control group, which indicate a 1 SD range of values for P3PT in the control group, are also shown
in the P3PT plot for the H-PSQI group. Red or blue lines indicate that the 1 SD range was calculated using P3PT data estimated from 2 or 3 genes, respectively. (For interpretation of
the references to color in this figure legend, the reader is referred to the web version of this article.)
M. Akashi et al. / EBioMedicine 62 (2020) 103080 7social time schedules, such as the start time of business or class. In
contrast, GUf is independent of social time schedules and is likely
synchronized with circadian-driven sleepiness. The time lag between
GUf and GUw is therefore a potential detection criterion for LCRSWD.
However, although GUf  GUw in the H-PSQI group was an average
of about 30 min longer, there was no statistically significant differ-
ence between groups. Thus, statistical comparison of these sleep tim-
ing parameters between the control and H-PSQI groups did not
provide any potential detection criteria for LCRSWD.
Next, we statistically compared P3PT and its derivative parame-
ters between groups. In LCRSWD, circadian-driven sleepiness and
habitual sleep timing are desynchronous on work days. Habitual
sleep timing on work days is defined by GUw and SOw, with the for-
mer being more affected by social time schedules and therefore likely
to desynchronize from circadian-driven sleepiness. Because P3PT can
be useful as a relative phase marker for circadian-driven sleepiness,
the severity of the desynchrony between circadian-driven sleepiness
and habitual sleep timing can therefore be evaluated based on the
time interval between P3PT and GUw. However, there was no statis-
tically significant difference in GUw  P3PT between groups. In con-
trast, SOw  P3PT was significantly larger in the H-PSQI group. As
described above, delayed sleep onset may be independent of circa-
dian dysfunction and SOw P3PT cannot therefore be a specific crite-
rion for LCRSWD.Taken together, although we focused on GUf  GUw and
GUw  P3PT as potential criteria for LCRSWD, there was no statisti-
cally significant difference between the control and H-PSQI groups.
We speculate that statistical approaches were unable to identify
detection criteria for LCRSWD because the contribution of LCRSWD
to sleep problems in the H-PSQI group was unexpectedly minor.
4.3. Correlation between estimated circadian phases and sleep
parameters
The sample size of the present study was insufficient to conduct
correlation analysis and interpretation of the results of this analysis
was limited due to the low statistical significance. However, the
results provided a helpful indication of which among habitual sleep
parameters affects circadian phase and what we should focus on to
identify detection criteria for LCRSWD.
A moderate positive correlation between P3PT and GUw or SOw
in the control group demonstrated that habitual sleep timing on
work days affects P3PT. In contrast, there was lower or little correla-
tion between P3PT and GUf or SOf. Given the ratio of free to work
days per week, it makes sense that P3PT was more synchronous with
sleep parameters on work days.
In contrast to the control group, there was no correlation between
P3PT and GUw in the H-PSQI group. Although this result seems
Fig. 4. Validation of detection criteria for LCRSWD through follow-up investigations
(a) About two months after the assessment shown in Fig. 3, a second assessment was conducted for H-PSQI subjects with GUf  GUw > 2 h or GUw  P3PT < the mean  SD of
the control group in the first assessment. Subjects M and P, who met neither of the criteria in the first assessment, were recruited as negative control subjects.
(b) Subjects C, I and L performed circadian amelioration for a period of several weeks (C, 24 days; I, 23 days; L, 30 days). They continued to perform circadian amelioration for as
long as possible (C, 79 days; I, 37 days; L, 84 days, in total).
(a and b) GUf  GUw (yellow bars) and GUw  P3PT with 95% CI (dot plots) are shown for each subject. Red and blue dots indicate that P3PT was estimated based on expression
of two and three clock genes, respectively. The 1 SD range of GUw  P3PT for the control group in Fig. 3 is again shown on these dot plots (red lines, estimation from 2 genes; blue
lines, estimation from 3 genes).
(c and d) Clock gene expression rhythms of Subjects C, I and L before (day 0) and after circadian amelioration. A mathematical estimation of P3PT was performed based on the
expression levels of two (c) or three clock genes (d). Coloured curves and dots represent estimated and experimental values, respectively. Estimated P3PT values are shown below
the curves (N.D., not determined). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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GUw  P3PT between the control and H-PSQI groups, it likely
resulted from the high individual differences in the time interval
between P3PT and GUw in the H-PSQI group. In fact, the SD value of
GUw  P3PT was larger in the H-PSQI group, suggesting the possibil-
ity that a proportion of the subjects in the H-PSQI group had LCRSWD
due to desynchronisation between the habitual sleep timing and cir-
cadian-driven sleepiness.
These results suggest that interindividual, rather than intergroup,
comparison of the time interval between GUw and P3PT may provide
useful information for defining detection criteria for LCRSWD.
4.4. Identification of detection criteria for LCRSWD
To identify detection criteria for subjects with LCRSWD, who
likely comprise a minority of the H-PSQI group, circadian and sleep
parameters were compared at the individual level. Since GUw and
GUf are likely affected by social time schedules and circadian-driven
sleepiness, respectively, GUf  GUw should be strikingly long in sub-
jects with LCRSWD. Based on this criterion, Subjects C and L showed
a GUf  GUw of four hours, strongly suggesting that their circadian-
driven sleepiness was abnormally delayed in comparison with social
time schedules. They are therefore strong candidates for LCRSWD.Although GUf  GUw may be a promising simple detection crite-
rion for LCRSWD, this parameter can be affected by various non-cir-
cadian factors such as sleep debt. To further confirm LCRSWD,
additional validation based on clock gene expression was indispens-
able. Interindividual comparison of P3PT and its derivative parame-
ters between groups revealed that GUw  P3PT showed larger
individual differences in the H-PSQI group, supporting our explana-
tion for the loss of correlation between GUw and P3PT in this group.
We therefore focused on H-PSQI subjects with a high or low
GUw  P3PT value as potentially having LCRSWD.
Most of the H-PSQI subjects with a GUw  P3PT greater than the
mean + SD of the control group also had a SOw  P3PT greater than
the mean + SD of the control group. This indicates that their circa-
dian-driven sleepiness was phase-advanced in comparison with their
habitual sleep timing, which in turn suggests the presence of
LCRSWD caused by advanced circadian-driven sleepiness. However,
individuals with sleep problems often have a delayed habitual bed-
time or difficulties with sleep onset independent of circadian dys-
function, which in turn delays sleep offset to maintain total sleep
duration. It is therefore more plausible that, rather than their circa-
dian-driven sleepiness being advanced, their SOw and GUw were
delayed independently of circadian dysfunction. That is, the individu-
al’s circadian-driven sleepiness, as a result rather than a cause of
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ual sleep timing. Hence, LCRSWD is not likely to be a major contribu-
tor to sleep problems in H-PSQI subjects with a GUw  P3PT greater
than the mean + SD of the control group.
In contrast, H-PSQI subjects with a GUw  P3PT less than the mean
 SD of the control group, none of whom suffered from early-morning
awakening, were thought to have LCRSWD because their circadian-
driven sleepiness was delayed in comparison to their habitual sleep
timing. Importantly, while Subjects C and L, strong candidates for
LCRSWD based on GUf  GUw, had values inside the 1 SD range of the
control group in P3PT, SOw  P3PT, GUf  P3PT and SOf  P3PT, they
had a GUw P3PT value less than the mean SD of the control group.
Taken together, we concluded that individuals that met the fol-
lowing two criteria likely had LCRSWD due to delayed circadian-
driven sleepiness: a GUf  GUw of about three hours or more and a
GUw  P3PT less than the mean  SD of the control group. As an
exception to the latter criterion, markedly low CD and/or large 95% CI
in mathematical estimation of P3PT also indicates LCRSWD. However,
in addition to Subjects C and L in the H-PSQI group, one subject in the
control group also met these criteria. This suggests that meeting
these criteria is required but not sufficient for the development of
sleep problems. Therefore, additional factors, such as the chronicity
of circadian misalignment, may be required for the development of
LCRSWD.
4.5. Validation of detection criteria for LCRSWD
To further validate the reliability of our detection criteria for
LCRSWD, we confirmed the reproducibility of candidate screening as
well as sleep improvement by circadian amelioration through follow-
up investigations.
If our detection criteria were appropriate, our candidate screen
should reproducibly identify the same subjects as having LCRSWD at
a later date. After about two months, a second screen based on the
same criteria was therefore conducted on H-PSQI subjects. Compared
to the first assessment, GUf  GUw remained at about four hours in
Subjects C and L and increased to more than four hours in Subject I.
GUw  P3PT was reproducibly and newly less than the mean  SD of
the control group in Subjects L and I, respectively. Although
GUw  P3PT appeared to improve in Subject C, surprisingly, clock
gene expression remained mostly constant, as can be expected from
a large 95% CI for GUw  P3PT. We have not encountered a subject
with arrhythmic clock gene expression in any of our previous data
using hair follicle cells from healthy and unhealthy subjects, strongly
suggesting that Subject C had a severe circadian dysfunction. Even
though Subjects B, F, H and K met neither of the criteria in the second
assessment, their PSQI scores remained high, suggesting that circa-
dian dysfunction may not be the main cause of sleep problems in
these four subjects. Subjects C, K and L met both criteria for GUf 
GUw and GUw  P3PT in the first assessment, and Subjects C, I and L
met these criteria in the second assessment. Hence, our candidate
screen reproducibly identified the same subjects (C and L) as having
LCRSWD at a later date, and this reproducibility supports the reliabil-
ity of our detection criteria for LCRSWD.
Subjects with LCRSWD who were successfully identified through
our detection criteria were expected to show improved sleep follow-
ing circadian amelioration because their sleep problems should be
largely attributable to circadian dysfunction. Subjects C, I and L aimed
to ameliorate circadian misalignment for three or four weeks. Circa-
dian rhythms of Subjects I and L were considered to have been suc-
cessfully adjusted because their GUf  GUw was shorter than in the
first and second assessments and their GUw  P3PT was within the 1
SD range of the control group. As expected, they had a lower PSQI
score. However, although P3PT had steadily advanced in Subject I, in
Subject L, it had advanced four weeks after the start of circadian ame-
lioration but subsequently reversed back to the original value.Nevertheless, sleep continued to improve in Subject L probably
because GUw  P3PT remained within the 1 SD range due to a large
delay in GUw. This confirms that the circadian phase relative to GUw,
rather than the absolute circadian phase, is important for normal
sleep. In contrast, no improvement was observed in the PSQI score in
Subject C. Although clock gene expression in Subject C did not show
clear circadian rhythms before the start of circadian amelioration,
about three weeks later, transcriptional oscillation was restored and
GUw  P3PT was within the normal range. The reason for the lack of
sleep improvement is probably that GUf  GUw exceeded five hours.
About eight weeks after the start of circadian amelioration, whereas
GUf  GUw improved in Subject C, GUw  P3PT had reversed back to
being less than the mean  SD of the control group. Hence, these
results demonstrate that simultaneous improvement in GUf  GUw
and GUw  P3PT is likely required for sleep improvement.
Taken together, these findings indicate that circadian ameliora-
tion resulted in sleep improvements in these subjects in the expected
manner, again supporting the reliability of our detection criteria for
LCRSWD.
5. Conclusions and limitations
The present study describes a successful prototype of a detection
method for LCRSWD. Specifically, we demonstrated that a criterion
based on GUw  P3PT is promising for the detection of LCRSWD
caused by delayed circadian-driven sleepiness. As an exception,
markedly low CD and/or large 95% CI in the estimation of P3PT also
indicates LCRSWD. In addition, we demonstrated that GUf  GUw is
useful as a simple initial criterion before proceeding to experimental
evaluation of GUw  P3PT. Follow-up investigations conducted to
confirm the reproducibility of candidate screening and sleep
improvement by circadian amelioration supported the reliability of
these detection criteria. In addition, successful validation of circadian
phase estimation at three time points increased the practicality of
our method, eliminating the need to interrupt subjects’ sleep for sam-
ple collection.
However, several limitations remain. First, more reliable defini-
tion of the detection criteria for LCRSWDmay require additional rules
for subject recruitment and further validation using classified sub-
jects. As an example of the former, although subject’s past medical
history was self-reported in the present study, some psychological
monitoring may be required during subject recruitment because psy-
chological status strongly affects sleep. As an example of the latter,
our detection criteria may vary depending on age and/or sex. Second,
sleep assessment was based only on PSQI in the present study.
Although PSQI is a widely used and highly reliable questionnaire for
evaluating sleep problems around the world [33,34], additional sleep
evaluation based on objective parameters will further strengthen our
conclusions. Further, in addition to self-reporting using MCTQ, habit-
ual sleep timing should be objectively monitored using wearable
devices. In particular, sleep debt during work days should be esti-
mated based on total sleep duration because it affects GUf  GUw.
Third, improving the accuracy of circadian phase estimation may be
required to accelerate practical use. This can be realized by optimiz-
ing experimental conditions and identifying additional clock genes
whose expression levels are measurable with high accuracy. How-
ever, increasing measurements results in increased effort and cost.
Fourth, in the present study, we validated our detection criteria for
LCRSWD by confirming the reproducibility of candidate screening
and sleep improvement by circadian amelioration. Although it took
about two months and more than three weeks to perform these
respective observations, it may be possible to increase the robustness
of the validation by further extending the observation period of these
follow-up experiments. Fifth, our present results revealed that the
contribution of LCRSWD to sleep problems in the H-PSQI group was
unexpectedly small. Only three among 23 subjects met the detection
10 M. Akashi et al. / EBioMedicine 62 (2020) 103080criteria for LCRSWD. The original sample size was therefore insuffi-
cient to perform robust follow-up experiments. More extensive trials
are required to further validate our detection method for LCRSWD.
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